Trieu Vuong (CIK 1587074) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy OTLC (240,000 shares), Buy OTLC (115,000 shares), Buy OTLC (75,000 shares), Buy OTLC (65,000 shares), Buy OTLC (239,759 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO | Buy | 240,000 | $10,344 |
| 2026-06-24 | Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO | Buy | 115,000 | $5,175 |
| 2026-06-24 | Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO | Buy | 75,000 | $3,375 |
| 2026-06-24 | Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO | Buy | 65,000 | $2,925 |
| 2026-06-17 | Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO | Buy | 239,759 | $10,693 |
| 2026-06-17 | Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO | Buy | 96,000 | $4,320 |
| 2025-07-10 | Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO | Buy | 104,000 | $0 |
| 2025-07-10 | Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO | Buy | 1 | $0 |
| 2025-07-10 | Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO | Buy | 94,736 | $0 |
| 2025-01-31 | Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO | Buy | 183,066 | $5,492 |
| 2025-01-31 | Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO | Buy | 100,003 | $3,000 |
| 2025-01-31 | Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO | Buy | 63,775 | $1,913 |
Source: SEC Form 4 filings · as of 2026-07-02